In commemoration of 11F, the International Day of Women and Girls in Science, IBUB collaborates with the promotion of science among girls in upper secondary school and above, inviting groups of girls to learn about the work of science in laboratories from women researchers with a passion for science. The aim is for them to
The Institute of Biomedicine of the University of Barcelona already has a registration code in the ROR (Research Organization Registry) database, a global, community-led registry of open persistent identifiers for research organizations.
CSIC publishes the ranking of researchers in Spain and Spaniards working aborad, according to their personal public profiles on Google Scholar among 123.400 profiles ranked first by h-index in decreasing order and then by the total number of citations. The data for this edition data was collected during the third week of November 2023. Special
A new study, led by the Department of Pharmacology, Toxicology and Therapeutic Chemistry of the University of Barcelona, the Institute of Biomedicine of the University of Barcelona (IBUB) and CIBERDEM, describes the effects of a compound PROTAC (Proteolysis-targeting Chimera) directed against soluble epoxide hydrolase (sEH). This compound, by stimulating the degradation of sEH, causes the
The IBUB Research Day is an event that brings together IBUB researchers, to present and discuss the latest contributions of each research group.
Des de l’IBUB volem seguir promovent la incorporació de nous estudiants predoctorals vinculats a un projecte de recerca de l’Institut, dins el marc dels programes de doctorat de continguts biomèdics de la Universitat de Barcelona.
There are still many enigmas about the mechanism of action of the CERKL gene, which causes retinitis pigmentosa and other hereditary vision diseases. Now, a team from the University of Barcelona has described how the lack of the CERKL gene alters the ability of retinal cells to fight oxidative stress generated by light and triggers cell death mechanisms that cause blindness.
Andrea Alegre-Martí received the BBVA-SEBBM Award in the category “Protein Structure and Function” with the article “A hotspot for posttranslational modifications on the androgen receptor dimer interface drives pathology and anti-androgen resistance”.
An agreement between DBGen Ocular Genomics and Novartis España will enable the genetic identification of retinitis pigmentosa (RP) and Leber congenital amaurosis (LCA) in affected patients.
